In summary, our data show the interactions of HS-173 with ABCB1 and ABCG2, as well as providing experimental evidence that the overexpression of ABCB1 or ABCG2 in cancer cells is a novel mechanism of acquired resistance to the PI3K inhibitor HS-173. This evidence concerns the gene ABCG2 and cancer.